https://www.selleckchem.com/pr....oducts/1-phenyl-2-th
than food environment to elevated phosphorus.Background Prostate-specific membrane antigen (PSMA)-ligand positron-emission-tomography (PSMA-PET) is potentially useful for screening of castration resistant prostate cancer (CRPC) clinical trial target populations. Aim We investigated the impact of PSMA-PET on Prostate Cancer Clinical Trials Working Group 3 (PCWG3) clinical subtype classification when compared to conventional imaging (CI). Methods Multicenter retrospective study enrolling patients with (a) PSMA-PET for CRPC, (b
Like
Comment
Share
